D DEMENTIA DISCOVERY FUND
LIVE

Serial Number

79308667

Owner

SV Health Managers LLP

Attorney

Syed Abedi

Filing Date

Sep 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

D DEMENTIA DISCOVERY FUND Trademark

Serial Number: 79308667 • Registration: 6703551

D DEMENTIA DISCOVERY FUND is a trademark filed by SV Health Managers LLP on September 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SV Health Managers LLP (3 trademarks)

71 Kingsway
London WC2B6ST , GB

Entity Type: 99

Trademark Details

Filing Date

September 9, 2019

Registration Date

April 19, 2022

Published for Opposition

February 1, 2022

Goods & Services

Pharmaceutical and medical preparations and substances for the treatment of dementia; Pharmaceutical and medical preparations and substances for use in the treatment and prevention of dementia; Sanitary preparations for medical purposes; Pharmaceutical preparations, all for use in the treatment and prevention of brain diseases and degenerative dementia disorders; Antiseptic preparations; Prescription pharmaceuticals for humans as well as other pharmaceutical products for the treatment of dementia; Dietetic foods adapted for medical use, and dietary and health food supplements; Vitamins; Dietetic substances adapted for medical use, namely, food for babies, teens, adults, and elders; Homeopathic preparations and substances for the treatment of dementia; Medicated drinks; Anti-diabetic drugs; Hypertension medications; Steroid hormones; Non-steroidal anti-inflammatory drugs

Insurance agency and brokerage; Financial affairs and monetary affairs, namely, financial information, management, and analysis services; Real estate agency services; Financial services, namely, financing the medical research of others; Arranging of financing for humanitarian aid and development, including charitable fundraising and support services for research in dementia; Charitable fundraising regarding funding for dementia research; Charitable services, namely, providing financial assistance to disadvantaged persons for food, clothing, and health care; Financial sponsorship services of charitable musical entertainment, running and walking, food tasting, dinner and dance events; Financial services, namely, managing and monitoring of charitable funds supporting dementia research; Accepting and administering monetary charitable contributions, namely, distribution and allocation of charitable funds; Providing of information in the field of charitable monetary giving through corporate donations and payroll donations by employees; Information, advisory, and consultancy services in relation to the aforesaid services

Medical services; The provision of information, online via the Internet, on the subject of all aspects of dementia diseases and the prevention of all types dementia diseases; Medical services relating to the science of nutrition and the use of medical and pharmaceutical preparations and substances; Medical services in relation to the recommendation and prescribing of medicaments and medical products of all kinds; Medical services concerning dementia, namely, physician, nursing, midwifery, and hospital services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Hygienic and beauty care for human beings; Agricultural advice services; Dentistry services; Medical analysis for the diagnosis and treatment of individuals and groups of people with dementia related to x-ray examinations and taking blood samples; Pharmaceutical advice; Medical clinic services; Medical treatment services; Medical analysis services; Nursing services; Information, advisory, and consultancy services relating to all the aforesaid

Scientific and technological services, namely, research and design in the field of goods and services connected with dementia treatment; Scientific and technological services, namely, research and design in the field of goods and services connected with dementia; Industrial analysis and research services in the field of goods and services connected with dementia treatment to assure compliance with industry standards; Design and development of computer hardware and software; Design and development of computer hardware and software connected with dementia; Laboratory analysis in the field of goods and services connected with dementia treatment; Laboratory research in the field of goods and services connected with dementia treatment; Laboratory research services in the field of goods and services connected with dementia treatment; Scientific and technological services, namely, laboratory testing services in the field of goods and services connected with dementia treatment; Medical laboratory services; Medical and scientific research services in relation to the causes, symptoms, diagnosis, treatment and prevention of dementia; Genetic research concerning dementia; Provision of medical and scientific research facilities; Medical and scientific research laboratories; Medical and scientific research in relation to medicines and pharmaceuticals; Medical research services; Design and development of software in the field of mobile device applications; Design and development of computer programmes

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 17, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 17, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2025 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 22, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 1, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 1, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 19, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 19, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 1, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jan 29, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 12, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 12, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 12, 2022 NONP
ASSIGNED TO LIE
Dec 29, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 27, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 22, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 3, 2021 GNFN
FINAL REFUSAL E-MAILED
Dec 3, 2021 GNFR
FINAL REFUSAL WRITTEN
Dec 3, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jun 26, 2021 NREP
REFUSAL PROCESSED BY IB
May 31, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 3, 2021 RFCS
REFUSAL PROCESSED BY MPU
May 3, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 28, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 20, 2021 MAFR
ASSIGNED TO EXAMINER
Apr 16, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 15, 2021 REPR